Copay Accumulator Lawsuit Comes to an End; Will Ruling Be Enforced?
-
Feb 08, 2024
An ongoing lawsuit over the use of copay accumulators is drawing to a close following the defendants’ and plaintiffs’ motions to dismiss their appeals. The ball is now in the federal government’s and state insurance commissioners’ courts to enforce a district court judge’s ruling, which states that manufacturer assistance must be counted toward patients’ out-of-pocket responsibility unless a brand-name drug has a medically appropriate generic equivalent.
Health plans and PBMs several years ago began implementing copay accumulators — and then a new iteration known as copay maximizers that declare certain drugs non-essential health benefits to avoid covering them per the Affordable Care Act (ACA) — to counter manufacturer copay assistance programs. Before these tools, that assistance would count toward beneficiaries’ annual out-of-pocket expenses. When those out-of-pocket maximums were reached, health plans would cover the remainder of members’ costs for the year. With accumulators and maximizers, patients can still use that assistance, but it does not help reduce those out-of-pocket costs.
Read more
© 2024 MMIT
Related Posts
-
![]()
Jan 11
Legal Battle Over Copay Accumulators Continues; Questions Remain Over HHS Policy Enforcement
Read more -
![]()
Dec 14
HHS Pushes Back on Accumulator Ruling, Prompting Wait-and-See Situation
Read more -
![]()
Oct 12
Increase in Patient Adherence Likely Will Follow Ruling Against Copay Offset Programs
Read more
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.